SCHEMBL4710366

SCHEMBL4710366

CC(=O)Oc1ccc(C)nc1C=Cc1ccc(Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
MAPK1 P28482 2/20 0.42
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
KDM4E B2RXH2 3/20 0.40
MAPT P10636 3/20 0.40
HPGD P15428 3/20 0.40
TP53 P04637 3/20 0.40
NPSR1 Q6W5P4 2/20 0.40
NFKB1 P19838 2/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
AMY1A P0DUB6 1/20 0.40
ALDH1A1 P00352 2/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4710365 1.00 LMNA (0.42) LMNASMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL4710439 0.88 KMT2A (0.40) LMNASMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL4710440 0.88 KMT2A (0.40) LMNASMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL4789553 0.85 CYP1A2 (0.43) LMNASMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL4789552 0.85 CYP1A2 (0.43) LMNASMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL4710055 0.79 KMT2A (0.44) LMNASMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL4710053 0.79 KMT2A (0.44) LMNASMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL4715316 0.78 MEN1 (0.51) LMNASMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL4715315 0.78 MEN1 (0.51) LMNASMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL4710561 0.75 ALOX5 (0.49) LMNASMN1; SMN2NPC1RAB9AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP claimed
EP-0998459-A2 PYRIDINE DERIVATIVES Novartis AG (CH) 2000-05-10 EP claimed
WO-1999002497-A2 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 1999-01-21 WO claimed
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP disclosed